Banner for leaf pages 2

Fondaparinux (Arixtra)

Also known as Arixtra

Fondaparinux (trade name Arixtra) is an anticoagulant medication chemically related to low molecular weight heparins. It is marketed by GlaxoSmithKline. A generic version developed by Alchemia is marketed within the US by Dr. Reddy's Laboratories.

Source: Wikipedia

Estimated Total Cost: $1244.77 for an average of 14 days supply

What is it prescribed for?

Patients are most commonly prescribed fondaparinux to treat deep vein thrombosis (dvt), pulmonary embolism, blastomycosis, and rabies.

What drug interactions are known?

Do not take fondaparinux if you are taking any of the following:

Critical Interactions


Significant Interactions

What side effects are related?

Patients taking fondaparinux most commonly experience side effects like fever, nausea, and anemia.

Ajax-loader Loading...